Search

everythinglearnresearchcommunity

for

Search:↓

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Both steroids effectively promote hair growth for at least 9 months.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.

Chemicals called 4-(alkylthio)- and 4-(arylthio)-benzonitrile derivatives can potentially reduce oil production on skin, which could help treat conditions like acne and hair loss.

Tofacitinib and oral minoxidil together effectively regrow hair in severe alopecia areata patients.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

The compounds tested could potentially treat hair loss and alopecia.

Antiandrogens help improve developmental delays caused by valproic acid in rats.

RXR agonists may promote hair growth in humans.

Both tofacitinib and ruxolitinib are effective and tolerable for treating alopecia areata.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

Prostaglandin F2alpha and related compounds can increase hair growth and darken hair in mice.

Testosterone increases hamster hair growth; cyproterone acetate reduces it.

ADT for prostate cancer may harm the heart, but GnRH antagonists might be safer.

Some dermatologists in Saudi Arabia prescribe Tofacitinib for hair loss, but many don't due to its unavailability and safety concerns.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

A new compound was created in 2010 that can control oil production when applied to the skin, and its effects are completely reversible after two weeks.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

Baricitinib is effective for Alopecia Areata but requires careful patient history evaluation.

Tofacitinib effectively treated severe hair loss in a patient who didn't respond to other treatments.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

Using tretinoin with triamcinolone acetonide helps treat alopecia areata.